2018. Analysis of the association between CFH Y402H polymorphism and response to intravitreal ranibizumab in patients with neovascular age-related macular degeneration (nAMD). Biomolecules and Biomedicine. 18, 3 (Aug. 2018), 260–267. DOI:https://doi.org/10.17305/bjbms.2018.2493.